Hutchmed (China) Limited American Depositary Shares (0J7G)
LSE
Closed
Aug 25, 2026
Day's Range
12.1852 wk Range
9.88Overview - 0J7G - Hutchmed (China) Limited American Depositary Shares
Key Statistics
Valuation
Enterprise Value
851.90M
Price / Book
‪1.68‬
EV / EBITDA
‪-41.52‬
Profitability
Profit Margin
‪3.25%‬
Operating Margin
‪0.31%‬
Return on Assets
‪-1.23%‬
Return on Equity
‪1.46%‬
Ownership
Float
104.58M
Held by Insiders
‪0.0089%‬
Held by Institutions
‪2.69%‬
Price stats
Beta
‪0.43‬
Peers - 0J7G - Hutchmed (China) Limited American Depositary Shares
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0J7GLSEHutchmed (China) Limited American Depositary Shares-29.38%52-week change—P/E (Trailing)‪3.25%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB+35.36%52-week change47.34P/E (Trailing)‪15.54%‬Profit Margin
- 0LERLSETeva Pharmaceutical Industries Ltd. ADR+51.35%52-week change30.16P/E (Trailing)‪51.78%‬Profit Margin
- 0A5VLSEViatris Inc.+35.37%52-week change10.73P/E (Trailing)‪11.88%‬Profit Margin
- CRDLLSECordel Group Plc+49.39%52-week change-6500.00P/E (Trailing)‪-27.15%‬Profit Margin
- SEMGLSEAmundi MSCI Semiconductors UCITS ETF Acc+43.58%52-week change—P/E (Trailing)—Profit Margin
- 0AAJLSEPolyPeptide Group AG+36.47%52-week change0.29P/E (Trailing)‪3.14%‬Profit Margin
Profile Summary - 0J7G - Hutchmed (China) Limited American Depositary Shares
About
Hutchmed (China) Limited American Depositary Shares represent shares in HUTCHMED (China) Limited, an innovative, commercial-stage biopharmaceutical company. It specializes in the discovery, global development, and commercialization of targeted therapies and immunotherapies for cancer and immunological diseases. The…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
